Latest Conference Articles

The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.

Understanding the role of abemaciclib (Verzenio) in managing patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer is crucial.

Amid rising cancer care costs, a focus on chemotherapy stewardship may result in cost savings, according to a session of the HOPA Practice Management 2020 Virtual Learning Event.

Introducing an online PharmD program presents a unique set of challenges for educators.

Women comprise more than 60% of pharmacy graduates, yet gender gaps still exist in pharmacy ownership, school deanships, and other leadership positions.

Mental health first aid training is being incorporated into pharmacy curricula to address suicide prevention and other crises.

In-person contact is one of the best ways to reduce existing stigma toward patients with mental illness in the field of pharmacy.

As more Americans identify as LGBTQIA+, an effort needs to made to educate pharmacists on LGBTQIA+ health and culture.

Habits are not set in stone, as there are biological pathways that researchers have explored that highlight how mindset can be beneficial in changing preexisting habits.

Steps are being taken to uphold the integrity of the pharmacy technician certification exam.

Relatively simple activities such as this not only enable students to actively engage in the material and encourage self-reflection, but Middendorf emphasized that they are also essential to preparing students to be active participants in an interprofessional care team.

The COVID-19 pandemic has revealed structural inequalities in health care and has brought many issues of health equality to the forefront of public consciousness.

In the part 2 of a Pharmacy Times interview with Lucinda Maine, PhD, RPh, CEO of AACP and Lynette Bradley-Baker, PhD, CAE, senior vice president for strategic engagement at AACP, the 2 discussed how pharmacy schools are planning for the upcoming academic year and the future.

As the role of the pharmacist grows, so too does the role of the pharmacy technician.

Pharmacy Times spoke with Lucinda Maine, PhD, RPh, CEO of the American Association of Colleges of Pharmacy (AACP), and Lynette Bradley-Baker, PhD CAE, senior vice president for strategic engagement at AACP.

Pharmacy technicians complete 56% of tasks related to medication history collection and reconciliation, according to Sasser.

At the National Pharmacy Technician Association’s virtual Pharmacy Technician Student Summit, Jamie McGuire, the pharmacy technician program director, discussed the role of professionalism in the lives of pharmacy technician students.

Heldenbrand said many patients look to the internet for answers and increasing numbers of patients are turning to YouTube.

The objective of the study was to examine a large clinical dataset of LGSC through the Ovarian Cancer Association Consortium, with the primary goal of identifying factors that affect survival.

A study presented at the Society of Gynecologic Oncology 2020 Annual Meeting on Women’s Cancer showed menstrual cups may provide a novel, less invasive, and more comfortable approach to the diagnosis of endometrial cancer.

With new and varying options for maintenance therapy in patients with ovarian cancer, patients may express a preference when discussing potential maintenance treatments and their adverse effects.

According to a recent study presented at the ADA’s 80th Scientific Sessions, youth and young adults with type 1 diabetes (T1D) in the United States today have worse glycemic control than prior generations.

Treatment of recently diagnosed patients with type 1 diabetes (T1D) with anti-IL-21 and liraglutide for 54 weeks was found to be safe and resulted in sustained insulin secretion and lower insulin dose.

The DPPOS is the long-term follow-up of the Diabetes Prevention Program (DPP), a multicenter trial conducted from 1996 to 2001 that established the success of either an intensive lifestyle program or treatment with metformin to prevent or delay the development of T2D in individuals who were considered at high risk for developing the disease.

Oral insulin (OI) slows insulin decline in those at high risk for type 1 diabetes (T1D), according to a poster session at the American Diabetes Association’s 80th virtual Scientific Sessions.

There have not been many evaluations of the prevalence of, and factors associated with, use of DSME/S and support programs in newly diagnosed patients with type 2 diabetes (T2D) in Louisiana, according to the study authors.

The slowed metabolic decline among the OI trial participants at highest risk was assessed and defined by the DPT1 Risk Scores over a 6.75 threshold.

The TEDDY study also aims to identify environmental triggers that cause the immune destruction of beta cells.